What does progression mean for Ovarian Cancer and what happens next

Understanding Progression in Ovarian Cancer

I'm glad you're asking about this important concept. Let me explain what progression means and what typically happens next in ovarian cancer care.

What Does Progression Mean?

Progression means that your cancer is growing or spreading despite treatment. According to the NCCN Guidelines for Ovarian Cancer, progression can show up in a few different ways:

• New tumors appearing in areas where there was no cancer before
• Existing tumors getting larger on imaging scans (CT, MRI, or PET scans)
• Rising tumor markers like CA-125 levels increasing over time
• New symptoms appearing that suggest cancer growth (like increased abdominal pain or fluid buildup)

Doctors distinguish between different types of progression:

• During treatment: Cancer grows while you're actively receiving chemotherapy or other therapy
• After treatment: Cancer returns after you've completed initial treatment (this is called "recurrent disease")
• Rising CA-125 only: Your tumor marker increases, but imaging doesn't yet show visible disease

What Happens Next: The Clinical Approach

According to NCCN Guidelines, when progression is identified, your care team follows a structured approach:

STEP 1 - EVALUATION & CONFIRMATION

Your oncologist will:

• Perform imaging studies (chest/abdominal/pelvic CT, MRI, PET/CT, or PET scans) to confirm progression and see where the cancer is located
• Check tumor markers like CA-125 to track disease activity
• Review your complete medical history, including what treatments you've already received and how you responded
• Assess your overall health (performance status) to determine what treatments are safe for you

STEP 2 - MOLECULAR TESTING (If Not Previously Done)

The NCCN Guidelines emphasize that tumor molecular testing is important if you haven't had it already. This includes testing for:

• BRCA1/2 mutations (genetic changes that affect treatment options)
• HRD status (homologous recombination deficiency - helps predict response to PARP inhibitors)
• Other biomarkers like MSI, MMR, and tumor mutational burden

This testing helps your doctor select the most effective next treatment.

STEP 3 - TREATMENT DECISIONS

Your treatment options depend on several factors:

If you haven't received chemotherapy yet:

• Your doctor will likely recommend platinum-based chemotherapy (the standard first-line treatment)

If you've already had chemotherapy: Your options depend on:

• How long it's been since your last treatment ended
• How you responded to previous treatment
• Your BRCA/HRD status (which opens up targeted therapy options)
• Your overall health and ability to tolerate treatment

Common next-line approaches include:

1. PARP Inhibitors (if you have BRCA mutations or HRD-positive status)

   • Drugs like olaparib, niraparib, or rucaparib
   • These target specific genetic vulnerabilities in cancer cells
   • Often used as maintenance therapy after chemotherapy response

2. Bevacizumab (an anti-angiogenesis drug)

   • Cuts off blood supply to tumors
   • Often combined with chemotherapy

3. Chemotherapy (if you haven't had it recently)

   • Platinum-based regimens remain standard
   • May be combined with targeted therapies

4. Clinical Trials

   • New treatment combinations and approaches
   • May offer access to cutting-edge therapies

5. Palliative Care

   • Focuses on symptom management and quality of life
   • Can be used alongside active treatment

Important Clinical Context

According to the NCCN Guidelines, doctors consider this key principle: "Patients who do not respond and progress on two consecutive therapy regimens without evidence of clinical benefits have diminished likelihood of benefitting from additional therapy." This means your care team will have honest conversations about when to shift focus toward comfort and quality of life.

Questions to Ask Your Oncologist

When progression is identified, these questions can help guide your care:

1. What imaging or tests confirm the progression, and where is the cancer growing?
2. Have I had molecular testing (BRCA, HRD status)? If not, can we do it now?
3. What treatment options are available based on my specific situation and previous treatments?
4. What are the pros and cons of each option, and which do you recommend?
5. Are there clinical trials I might be eligible for?
6. What are realistic goals for the next treatment—cure, remission, or symptom control?
7. What side effects should I expect, and how will we manage them?
8. When should we reassess whether treatment is working?
9. Should we discuss palliative care to help manage symptoms alongside treatment?

The Bottom Line

Progression doesn't mean the end of your treatment journey. The NCCN Guidelines show that multiple treatment options exist for recurrent or progressive ovarian cancer, and your care team has a systematic approach to finding the best next step for YOUR specific situation. The key is working closely with your gynecologic oncologist to understand your options and make informed decisions together.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.